These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 30076018

  • 1. The effect of intratympanic steroid injection frequency in idiopathic sudden sensorineural hearing loss.
    Sugihara EM, Evans MA, Neumann M, Babu SC.
    Am J Otolaryngol; 2018; 39(6):688-692. PubMed ID: 30076018
    [Abstract] [Full Text] [Related]

  • 2. Comparison of 2 Different Intratympanic Methylprednisolone Injection Schedules in Combination With Intravenous Dexamethasone for Unilateral Sudden Sensorineural Hearing Loss.
    Lyu Y, Zeng F, Yan M, Zhou Z, Zhang W, Liu M, Ke C.
    Ear Nose Throat J; 2021 Jun; 100(3_suppl):309S-316S. PubMed ID: 32070130
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic steroid injection for sudden sensorineural hearing loss: Impact of injection interval on therapeutic efficacy.
    Kwak MY, Yang CJ, Shim HJ, Song CI, Kim JY, Lee IW, Jung SW, Lim HW, Kwon JK, Lee JH, Choi J, An YS, Lee KY, Chung JW.
    Auris Nasus Larynx; 2020 Dec; 47(6):982-989. PubMed ID: 32650961
    [Abstract] [Full Text] [Related]

  • 4. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss.
    Suzuki H, Koizumi H, Ohkubo J, Hohchi N, Ikezaki S, Kitamura T.
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3101-7. PubMed ID: 26879994
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss.
    Yoo MH, Lim WS, Park JH, Kwon JK, Lee TH, An YH, Kim YJ, Kim JY, Lim HW, Park HJ.
    Audiol Neurootol; 2016 Oct; 21(6):399-405. PubMed ID: 28384627
    [Abstract] [Full Text] [Related]

  • 6. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.
    Suzuki H, Wakasugi T, Kitamura T, Koizumi H, Do BH, Ohbuchi T.
    Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622
    [Abstract] [Full Text] [Related]

  • 7. The Efficacy of Concurrent or Sequential Intravenous and Intratympanic Steroid for Idiopathic Sudden Sensorineural Hearing Loss.
    Chu CH, Chiou SR, Wang MC, Shiao AS, Tu TY, Lin LY, Huang CY, Liao WH.
    Audiol Neurootol; 2018 Apr; 23(5):277-284. PubMed ID: 30537751
    [Abstract] [Full Text] [Related]

  • 8. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss.
    Baysal E, Tunç O, Baglam T, Durucu C, Oz A, Karatas ZA, Polat M, Celenk F, Mumbuc S, Kanlikama M.
    J Craniofac Surg; 2013 Mar; 24(2):432-4. PubMed ID: 23524709
    [Abstract] [Full Text] [Related]

  • 9. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss.
    Chou YF, Chen PR, Kuo IJ, Yu SH, Wen YH, Wu HP.
    Laryngoscope; 2013 Sep; 123(9):2264-9. PubMed ID: 23804460
    [Abstract] [Full Text] [Related]

  • 10. [A prospective controlled study on the proper time of intratympanic steroid for profound sudden sensorineural hearing loss of total frequency type].
    Zhong SX, Zuo WQ, Zhang BY, Qian Y, Lei Y.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Nov 07; 53(11):806-810. PubMed ID: 30453397
    [Abstract] [Full Text] [Related]

  • 11. [Intratympatic budesonide injection for treatment of refractorysudden sensorineural hearing loss].
    Sun RX, Zhao Y, Liu J.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun 20; 30(12):972-977. PubMed ID: 29771066
    [Abstract] [Full Text] [Related]

  • 12. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR.
    Otol Neurotol; 2011 Jul 20; 32(5):774-9. PubMed ID: 21646929
    [Abstract] [Full Text] [Related]

  • 13. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.
    Laryngoscope; 2007 Jan 20; 117(1):3-15. PubMed ID: 17202923
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intratympanic methylprednisolone administration promotes the recovery of idiopathic sudden sensorineural hearing loss: a retrospective case-control study.
    Jiang K, Li S, Cheng L, Yang J.
    Acta Otolaryngol; 2018 Nov 20; 138(11):998-1003. PubMed ID: 30465620
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.
    Gouveris H, Schuler-Schmidt W, Mewes T, Mann W.
    Otol Neurotol; 2011 Jul 20; 32(5):756-60. PubMed ID: 21646933
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy of combination therapy for idiopathic sudden sensorineural hearing loss.
    Jung da J, Park JH, Jang JH, Lee KY.
    Laryngoscope; 2016 Aug 20; 126(8):1871-6. PubMed ID: 26972103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.